Webinars and Podcasts
Impact of Platelet Transfusion on Pulmonary Function of Hematology Oncology Patients: The PIPER Study
Dr. Allison Wheeler of Vanderbilt University Medical Center discusses results from the PIPER Phase 4 Study – the largest study of platelet transfusion associated pulmonary injury to-date with >10,000 platelet components transfused in >2,000 patients.
PIPER, or “Pathogen Inactivated Platelets Entering Routine Practice,” compares the pulmonary safety of conventional and pathogen reduced platelet components transfused to hematology-oncology patients.
View Dr. Wheeler’s presentation originally presented at the 63rd ASH Annual Meeting, December 2021
Allison Wheeler, MD
Associate Medical Director, Blood Bank and Coagulation Laboratory
Vanderbilt University Medical Center